Bank of New York Mellon Corp cut its position in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 0.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 858,006 shares of the medical instruments supplier’s stock after selling 3,098 shares during the quarter. Bank of New York Mellon Corp’s holdings in West Pharmaceutical Services were worth $85,192,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Burt Wealth Advisors lifted its stake in West Pharmaceutical Services by 113.7% during the second quarter. Burt Wealth Advisors now owns 4,128 shares of the medical instruments supplier’s stock valued at $410,000 after buying an additional 2,196 shares in the last quarter. Macquarie Group Ltd. lifted its stake in West Pharmaceutical Services by 0.7% during the second quarter. Macquarie Group Ltd. now owns 107,213 shares of the medical instruments supplier’s stock valued at $10,645,000 after buying an additional 786 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its stake in West Pharmaceutical Services by 7.4% during the second quarter. Schwab Charles Investment Management Inc. now owns 345,633 shares of the medical instruments supplier’s stock valued at $34,318,000 after buying an additional 23,700 shares in the last quarter. Janus Henderson Group PLC lifted its stake in West Pharmaceutical Services by 27.1% during the second quarter. Janus Henderson Group PLC now owns 875,723 shares of the medical instruments supplier’s stock valued at $86,951,000 after buying an additional 186,752 shares in the last quarter. Finally, Sei Investments Co. lifted its stake in West Pharmaceutical Services by 56.0% during the second quarter. Sei Investments Co. now owns 85,778 shares of the medical instruments supplier’s stock valued at $8,517,000 after buying an additional 30,795 shares in the last quarter. 94.27% of the stock is owned by institutional investors.

WST stock opened at $110.98 on Friday. The company has a quick ratio of 2.23, a current ratio of 2.94 and a debt-to-equity ratio of 0.15. West Pharmaceutical Services Inc. has a one year low of $82.74 and a one year high of $125.09. The stock has a market cap of $8.23 billion, a price-to-earnings ratio of 39.92, a PEG ratio of 4.20 and a beta of 1.19.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings data on Thursday, October 25th. The medical instruments supplier reported $0.76 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.06. The company had revenue of $431.70 million during the quarter, compared to analyst estimates of $427.55 million. West Pharmaceutical Services had a net margin of 9.06% and a return on equity of 15.78%. Sell-side analysts predict that West Pharmaceutical Services Inc. will post 2.8 EPS for the current year.

WST has been the subject of a number of analyst reports. Zacks Investment Research raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $123.00 price objective for the company in a research note on Tuesday, July 31st. ValuEngine raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating in a research note on Wednesday, October 17th.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece of content on another publication, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://theolympiareport.com/2018/11/11/bank-of-new-york-mellon-corp-trims-stake-in-west-pharmaceutical-services-inc-wst.html.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Further Reading: Institutional Investors

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.